- Mar 17, 2009
- 1,863
- 0
- 0
BroDeal said:Who will you believe? Abt or a rider on Motorola? Abt cannot even bring himself to say that Armstrong doped. Bishop is probably the rider who recently contacted the USADA to say he is willing to help.
What about Steve Swart?
In his 12 years as a professional cyclist, Frankie Andreu was a domestique, a worker bee whose job was to help a top rider like Armstrong win.
He said his introduction to performance-enhancing drugs came in 1995, when he and Armstrong were with the Motorola team. He said some of the team’s riders felt that they could no longer compete with some European teams that had rapidly improved and were rumored to be using EPO.
Motorola’s top riders asked their doctor, Massimo Testa, about the drug’s safety because more than a dozen young riders in Europe had died mysteriously of heart attacks. Some cyclists had linked those deaths to rumored EPO use.
Dr. Testa, now a sports medicine specialist at the University of California at Davis, said in a telephone interview that he had given each rider literature about EPO, in case any of them decided to use it on their own.
Dr. Testa said he urged the riders not to take the drug, but he wanted them to be educated.
“If you want to use a gun, you had better use a manual, rather than to ask the guy on the street how to use it,” he said. “I cannot rule out that someone did it.”
One of Armstrong’s teammates, Steve Swart, has admitted using EPO while riding for Motorola. He discussed his time with the team in the book “L.A. Confidential: The Secrets of Lance Armstrong,” which was published in 2004, only in French.
The book’s allegations that Armstrong doped prompted the lawsuit between Armstrong and SCA Promotions, which was settled out of court in February. Because of Armstrong’s suspected drug use, SCA withheld a $5 million bonus after he won the 2004 Tour de France. Armstrong and Tailwind Sports, the company that owned his cycling team, sued SCA for the money.
Testimony in the case was never supposed to become public. A confidential settlement awarded Armstrong and Tailwind Sports the bonus, and $2.5 million in interest and lawyers’ costs. The Times obtained the legal documents in July.
In testimony in the case, Swart, a retired rider from New Zealand, said top riders on Motorola discussed EPO in 1995. He testified that Armstrong told teammates that there was “only one road to take” to be competitive. In a sworn deposition, Swart said the meaning of Armstrong’s comment was clear: “We needed to start a medical program of EPO.”
EPO, cortisone and testosterone were common in European cycling, Swart said in a telephone interview. He said using cortisone, a steroid, was regarded as “sucking on a candy stick.” Cyclists acquired the drugs from European pharmacies and took them in private, Swart said. “You basically became your own doctor,” he said.
He said signs of drug use were widespread at the 1994 and 1995 Tours, when there was no testing for EPO.
“Everyone was walking around with their own thermos, and you could hear the sound — tinkle, tinkle, tinkle — coming from the thermoses because they were filled with ice and vials of EPO,” Swart said. “You needed to keep the EPO cold, and every night at the hotel, the guys would be running around trying to find some ice to fill up their thermos.”
‘It Was for Lance’
http://www.nytimes.com/2006/09/12/sports/othersports/12cycling.html?pagewanted=print
